Prostatis Group’s Schwab US Mid-Cap ETF SCHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-487,581
Closed -$163K 208
2023
Q2
$163K Buy
+487,581
New +$11M 0.08% 116
2022
Q3
Sell
-11,715
Closed -$245K 70
2022
Q2
$245K Sell
11,715
-2,904
-20% -$67K 0.38% 34
2022
Q1
$370K Sell
14,619
-20,922
-59% -$524K 0.3% 48
2021
Q4
$953K Sell
35,541
-12,570
-26% -$335K 0.58% 38
2021
Q3
$1.23M Sell
48,111
-141
-0.3% -$3.68K 0.73% 37
2021
Q2
$1.26M Sell
48,252
-4,095
-8% -$106K 0.86% 34
2021
Q1
$1.3M Sell
52,347
-9,261
-15% -$225K 1.02% 25
2020
Q4
$1.4M Sell
61,608
-234
-0.4% -$4.88K 1.17% 21
2020
Q3
$1.14M Buy
61,842
+24,849
+67% +$460K 1.08% 26
2020
Q2
$649K Buy
36,993
+15,681
+74% +$256K 1.3% 27
2020
Q1
$300K Sell
21,312
-78,018
-79% -$1.43M 0.43% 33
2019
Q4
$1.99M Buy
+99,330
New +$1.92M 1.8% 18

Other funds holding SCHM

Prostatis Group's SCHM Position: Q3 2023 in Review

Prostatis Group sold out of Schwab US Mid-Cap ETF (SCHM) in Q3 2023, closing a stake of 487,581 shares — an estimated $163K sold.

Prostatis Group first reported a position in SCHM in Q4 2019 and held it in 12 quarters. The position peaked at $1.99M in Q4 2019. 776 funds tracked by Wall St. Rank hold SCHM as of Q3 2023.

  • Prostatis Group reported no remaining Schwab US Mid-Cap ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 487,581 Schwab US Mid-Cap ETF shares in Q3 2023, an estimated $163K.
  • Prostatis Group first reported a position in Schwab US Mid-Cap ETF in Q4 2019 and held it in 12 quarters.
  • Prostatis Group's Schwab US Mid-Cap ETF position peaked at $1.99M in Q4 2019.
  • 776 funds tracked by Wall St. Rank held Schwab US Mid-Cap ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.